Searched for
DHANUKA LABORATORIES
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...- Debt-free Orchid Pharma charts out growth planOrchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch...
- Orchid all set to generate enough cash to fund expansion plans: Manish Dhanuka“Three years back, when we started, we had a significant debt. But, today we are a debt-free company and we also have significant investmen...
- Stock market update: Nifty Pharma index falls 0.61% in a weak marketThe Nifty Pharma index was trading 0.61 per cent down at 12973.45.
- Stock market update: Nifty Pharma index falls 0.26%The Nifty Pharma index closed 0.26 per cent down at 13052.9.
- Stock market update: Stocks that hit 52-week lows on NSEBajaj Auto, UPL, Cipla, HUL and Nestle India were among the top losers on NSE.
- Stock market update: Stocks that hit 52-week highs on NSEHLV Ltd., HPL Electric Power, Axita Cotton, Salasar Techno Engg and Hindustan Foods, hit their fresh 52-week highs at 10:04AM.
- Stock market update: Nifty Pharma index falls 1.14%The Nifty Pharma index closed 1.14 per cent down at 13079.5.
- Stock market update: Nifty Pharma index advances 0.65%The Nifty Pharma index closed 0.65 per cent up at 12950.45.
- Corporate Radar: Dividends, rights issues, AGMs and Q4 earningsAt least five stocks will go ex-dividend today. They included Angel One, Caplin Point Laboratories, Coforge, Cyient and Dolat Algotech.
- Orchid Pharma hits lower circuit after promoter announces OFS at 72% discountThe offer for sale opened for subscription for non-retail investors and was subscribed 1.36 per cent so far. Retail investors can bid for t...
- Orchid Pharma announces OFS at 72% discountDhanuka, which took over the pharma company under the NCLT resolution process in 2018, announced selling 32.80 lakh shares representing an ...
- A 7,700% stock surge is about to face a reality check in IndiaOrchid is among a handful of Indian companies to post meteoric gains after exiting bankruptcy proceedings. Such rallies could pose consider...
- Buy Dhanuka Agritech, target price Rs 910: Emkay GlobalDhanuka Agritech Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 3354.57 Crore) operating in Pestici...
- Another Ruchi Soya in the making? This scrip jumps 6,100% in 4 monthsAnalysts are comparing this stellar run with the surge that Ruchi Soya shares saw after Ramdev’s Patanjali Group acquired the company last ...
- NCLAT stays sale of Orchid to DhanukaIn response to a petition filed by Accord Life Spec Private Ltd, a company promoted by DMK MP Jagatrakshagan’s family members, the NCLAT st...
- NCLT approves Dhanuka Lab’s Rs 1,116 crore plan to buy debt-hit Orchid PharmaA consortium of 24 banks has lent a total of over Rs 3,200 crore to the drug maker and the lenders will be taking a haircut of around 65%.
- Accord wants Orchid to reconsider its bidTaking its chance, Accord, which had lost out to Dhanuka, filed a petition on June 14 asking for its bid to be considered.
- Dhanuka Laboratories leads race for Orchid PharmaBesides Dhanuka, two other companies - Accord Life Spec and Covalent Laboratories - had bid for Chennai-based Orchid Pharma in a second rou...
- Nestle Maggi row: Food industry bodies seek clearer normsAccording to the industry executives, food companies are often in a fix about adhering to the classification system and procurement norms.
Load More
